It’s been an uncomfortable stretch for fans of Healthcare stocks, with names across the board losi... Read More
Noel Atkinson of Clarus Securities has dropped his target on Canadian specialty pharma company HLS ... Read More
Stifel GMP analyst Justin Keywood remains in a positive headspace about HLS Therapeutics (HLS Therap... Read More
The stock has pulled back significantly over the past few months but Stifel GMP analyst Justin Keywo... Read More
Rahul Sarugaser of Raymond James has cemented HLS Therapeutics (HLS Therapeutics Stock Quote, Chart,... Read More
Noel Atkinson of Clarus Securities continues to be behind HLS Therapeutics (HLS Therapeutics Stock Q... Read More
Pharmaceutical companies aren’t every investor’s jam, what with their risk/reward meter at the u... Read More
Noel Atkinson of Clarus Securities is staying bullish on HLS Therapeutics (HLS Therapeutics Stock ... Read More
Stifel GMP analyst Justin Keywood is staying bullish on HLS Therapeutics (HLS Therapeutics Stock Quo... Read More
Stifel GMP analyst Justin Keywood provided an update to clients on Monday where he argued there’s ... Read More
Ahead of third quarter earnings from specialty pharma company HLS Therapeutics (HLS Therapeutics Sto... Read More
Investors shouldn’t worry about the US patent decision when it comes to HLS Therapeutics (HLS Ther... Read More
A better sales outlook has Clarus Securities analyst Noel Atkinson boosting his price target on HLS ... Read More
A potential catalyst is coming up for HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News TS... Read More
In an update to clients last Friday, Stifel GMP analyst Justin Keywood said cardiovascular and centr... Read More
Stifel GMP analyst Justin Keywood released on Monday a flash update to clients, saying a new Health ... Read More
The United States District Court for ruling in favour of the generic companies versus Amarin and its... Read More
Following the company’s fourth quarter results, Stifel Canada analyst Justin Keywood has maint... Read More